Delivery Order SPE2DB24D2101-SPE2DB25FKPFF
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,131.67 on October 24, 2025, by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by October 27, 2025, with the place of performance at AmerisourceBergen's corporate office in Conshohocken. The delivery order was issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $43,474.14 by the Defense Logistics Agency on November 5, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by November 6, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a child delivery order under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $49,182.56 by the Defense Logistics Agency on August 13, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This firm fixed price delivery order, with an ultimate completion date of August 14, 2025, represents a non-competitive, non-set-aside award. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Eliquis 5 mg tablets in a quantity of 60 units. This firm fixed-price delivery order, valued at $9,921.90, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of September 15, 2025. The contract will be performed at the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $12,049.99 by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 26, 2025. The award was issued on August 25, 2025, with no set-aside designation applied. This delivery order is a child contract executed under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,157.96 by the Defense Logistics Agency (DLA) on July 28, 2025, with an ultimate completion date of July 29, 2025. The award is for the supply of Eliquis 5 mg tablets in a 60-count quantity, representing a firm fixed price, competitively awarded delivery order with no set-aside designation. This contract award is executed as a child order under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on April 24, 2025, by the Defense Logistics Agency to supply Eliquis 5 mg tablets (60-count packages) with a ceiling value of $38,436.76. This firm fixed-price delivery order, which has an ultimate completion date of April 25, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,995.06 by the Defense Logistics Agency on October 27, 2025, for the supply of Eliquis 5 mg tablets (60-count). The contract is a firm fixed price delivery order with an ultimate completion date of October 28, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is the contractor's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $20,029.67. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Eliquis 5 mg tablets in a quantity of 60 units. This competitively awarded, non-set-aside contract is valued at $3,833.64 and operates under firm fixed pricing, with an ultimate completion date of October 31, 2025. The place of performance is located in Conshohocken, Pennsylvania,...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPFFDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $33,649.89 by the Defense Logistics Agency (DLA) on September 5, 2025. The contract calls for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a firm fixed price structure and an ultimate completion date of September 8, 2025. This is a competitively awarded, non-set-aside contract that will be fulfilled at the vendor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceuticals and medical supplies to military healthcare programs worldwide. The Eliquis supply supports federal medical procurement needs for military and veteran healthcare systems, representing a routine pharmaceutical delivery within the company's extensive portfolio of medications and medical commodities provided to the Defense Health Agency and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.6k | 9/5/25 |